Physician profile
Courtney Webb Ridner
NPI 1346228426
$5,843.71
in general payments reported to CMS, 2019-2025
29 companies · $904 in 2025
The $904 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,104 · 2020: $433 · 2021: $598 · 2022: $877 · 2023: $820 · 2024: $1,107 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,732 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,732.22 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,341.94 | 2019-2025 | Centurion, Clareon, Luxor |
| Mallinckrodt Hospital Products INC. | $675.11 | 2020-2025 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $544.77 | 2019-2025 | Tecnis Iol, Veritas Vision System, Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $502.62 | 2019-2025 | Cequa |
| Abbvie INC. | $471.14 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $277.78 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $276.12 | 2019-2021 | |
| New World Medical,INC. | $272.75 | 2021-2024 | Clearpath, Streamline, Kahook Dual Blade |
| Ivantis, INC | $179.81 | 2019-2021 | |
| Allergan, INC. | $148.65 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $127.59 | 2022-2024 | Vyzulta, Miebo |
| Sight Sciences, INC. | $113.35 | 2019-2025 | Tearcare System, Omni Surgical System |
| Boston Scientific Corporation | $109.74 | 2025 | General - Erectile Dysfunction, General - Male Sui |
| Tarsus Pharmaceuticals, INC. | $104.11 | 2024-2025 | Xdemvy |
| Ocular Therapeutix, INC. | $96.34 | 2022-2023 | Dextenza |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $91.46 | 2019-2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $65.21 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $59.99 | 2019 | |
| Shire North American Group INC | $53.62 | 2019 | |
| Rayner Intraocular Lenses Limited | $52.11 | 2024-2025 | Rayner Cataract Set 1, Rayone Emv, Rayone Aspheric |
| Kala Pharmaceuticals, INC. | $51.17 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $49.36 | 2023 | Quatera 700 |
| Rxsight INC | $47.07 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Ani Pharmaceuticals, INC. | $31.98 | 2022-2023 | Purified Cortrophin Gel |
| Oyster Point Pharma, INC. | $24.19 | 2022 | |
| Biotissue Holdings INC. | $22.53 | 2024 | |
| Alcon Research LLC | $19.42 | 2019 | |
| Omeros Corporation | $17.39 | 2019 | |
| Eyevance Pharmaceuticals LLC | $16.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Courtney Ridner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.